Disulfiram Use in Patients With Abnormal Liver Function Test Results
J Clin Psychiatry 1998;59:313-316
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Background: Concern about the precipitation of severe
hepatitis by disulfiram often causes clinicians to avoid using
this effective treatment in patients who have elevated baseline
transaminase levels, even though no empirical evidence has so far
shown severe hepatotoxicity to be related to such laboratory
abnormalities. This study examines the effects of disulfiram in
alcohol-dependent patients with elevated liver function test
results and/or serologic evidence of hepatitis C virus (HCV)
Method: Hepatitis serologies and baseline
transaminase levels were obtained for 57 male alcoholics starting
treatment with disulfiram. Sequential liver function test results
were obtained for up to 12 weeks while subjects took disulfiram.
Results: Although subjects with elevated
baseline transaminase levels and serologic evidence of HCV
infection were the most likely to evidence marked elevations in
transaminase levels while taking disulfiram, most subjects took
disulfiram without other adverse consequences. In only 1 subject
did elevations appear directly related to disulfiram.
Conclusion: Monitoring of liver function test
results is warranted for patients taking disulfiram and permits
most patients with moderately elevated transaminase levels to
take it safely.